Quantitation of Murine Stroma and Selective Purification of the Human Tumor Component of Patient-Derived Xenografts for Genomic Analysis.
Quantitation of Murine Stroma and Selective Purification of the Human Tumor Component of Patient-Derived Xenografts for Genomic Analysis.
复制标题
DOI:
10.1371/journal.pone.0160587
复制
发表时间:
2016
期刊:
影响因子:
3.7
通讯作者:
Rudin CM
中科院分区:
文献类型:
--
作者:
Schneeberger VE;Allaj V;Gardner EE;Poirier JT;Rudin CM
Patient-derived xenograft (PDX) mouse models are increasingly used for preclinical therapeutic testing of human cancer. A limitation in molecular and genetic characterization of PDX tumors is the presence of integral murine stroma. This is particularly problematic for genomic sequencing of PDX models. Rapid and dependable approaches for quantitating stromal content and purifying the malignant human component of these tumors are needed. We used a recently developed technique exploiting species-specific polymerase chain reaction (PCR) amplicon length (ssPAL) differences to define the fractional composition of murine and human DNA, which was proportional to the fractional composition of cells in a series of lung cancer PDX lines. We compared four methods of human cancer cell isolation: fluorescence-activated cell sorting (FACS), an immunomagnetic mouse cell depletion (MCD) approach, and two distinct EpCAM-based immunomagnetic positive selection methods. We further analyzed DNA extracted from the resulting enriched human cancer cells by targeted sequencing using a clinically validated multi-gene panel. Stromal content varied widely among tumors of similar histology, but appeared stable over multiple serial tumor passages of an individual model. FACS and MCD were superior to either positive selection approach, especially in cases of high stromal content, and consistently allowed high quality human-specific genomic profiling. ssPAL is a dependable approach to quantitation of murine stromal content, and MCD is a simple, efficient, and high yield approach to human cancer cell isolation for genomic analysis of PDX tumors.
登录
查看更多内容
DOI:
10.1158/1541-7786.mcr-12-0307
发表时间:
2012-11
期刊:
Molecular cancer research : MCR
影响因子:
--
作者:
Karagiannis GS;Poutahidis T;Erdman SE;Kirsch R;Riddell RH;Diamandis EP
通讯作者:
Diamandis EP
影响因子:
82.9
作者:
通讯作者:
--
影响因子:
3.8
作者:
Gorges TM;Tinhofer I;Drosch M;Röse L;Zollner TM;Krahn T;von Ahsen O
通讯作者:
von Ahsen O
影响因子:
8.8
作者:
Liu, Jie;Kibiki, Gibson;Houpt, Eric
通讯作者:
Houpt, Eric
影响因子:
6.4
作者:
LEFRANCOIS, D;OLSCHWANG, S;DUTRILLAUX, B
通讯作者:
DUTRILLAUX, B